Matt Harris

Matt is the founder, former CEO (2010-2019) and currently Chief Scientific Officer of the Company.

Matt has approximately 20 years of combined experience in cancer research, nuclear medicine and business and has a PhD in cancer research from the Australian National University. Matt brings expertise in biotechnology, radiopharmaceuticals, academic research and investment to the Company and focuses on developing the technology behind the Company’s products.

Matt has an MBA from the Australian Graduate School of Management. He has held leading managerial positions and director roles in several early stage Australian life science companies.